Our state-of-the-art facility is just a 20-minute drive from San Diego.
After oral treatment, the disease appeared to remain active, as 40.0% of patients in the placebo group and 26.7% in the adalimumab group developed at least one new erosive interphalangeal joint in 3.6% and 2.1% of their non-erosive interphalangeal joints, respectively, during the 12-month follow-up period, demonstrating that adalimumab has no therapeutic effect on degenerative OA of the hand
We need to ensure that patients arent losing the strength and endurance that help them stay active and independent. The takeaway: As GLP-1s become more common, obesity care must evolve to prioritize not just weight loss, but physical function and long-term health.
While the benefits and drawbacks of semaglutide are clear, several additional factors should be weighed before starting treatment
Available in Australia with fast dispatch, this compound supports extended laboratory workflows
Yu H, Mistry J, Nicar MJ, Khosravi MJ, Diamandis A, Van Doorn J et al